Skin care thought leader Katerina Steventon explores the causes and potential cosmetic treatments of acne in male consumers
Recently, the landscape of skin care claims has been challenged by the Advertising Standards Authority (ASA), which is banning skin care adverts that target acne with 'medicinal claims'.
Major names affected include Clearasil, Dermalogica and Johnson & Johnson (J&J). They were ordered to remove online campaigns that made 'medicinal claims', eg Dermalogica's to "treat, clear and prevent adult acne" and "provide around-the-clock, maximum control of the main factors that contribute to acne".
A proposal from Dermalogica to replace "acne" with the terms "breakout" or "blemish" was not deemed sufficient by the ASA. The ASA argued that acne is . . .
This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.
Subscribe now to premium content on Cosmetics Business